Bruker Corporation (BRKR)

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
United States Revenue	921.10M	891.30M	938.50M
Germany Revenue	303.90M	297.00M	310.70M
Europe excluding Germany Revenue	1.02B	950.20M	873.00M
China Revenue	438.80M	475.80M	471.20M
Rest of Asia Pacific Revenue	540.90M	552.60M	518.50M
Total Asia Pacific Revenue	979.70M	1.03B	989.70M
Other Countries Revenue	279.00M	269.60M	254.50M
Revenue (Total)	3.50B	3.44B	3.37B

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
BSI BioSpin Revenue	868.90M	878.80M	905.70M
BSI CALID Revenue	1.27B	1.21B	1.09B
BSI Life Science Revenue	2.14B	2.09B	2.00B
BSI Nano Revenue	1.08B	1.08B	1.10B
Total BSI Revenue	3.22B	3.17B	3.10B
BEST Revenue	286.40M	270.90M	283.00M
Eliminations from Revenue	-9.50M	-7.70M	-14.10M
Revenue (Total)	3.50B	3.44B	3.37B

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
BSI BioSpin Operating Income	13.90M	104.30M	157.80M
BSI CALID Operating Income	175.90M	153.30M	180.00M
BSI Life Science Operating Income	189.80M	257.60M	337.80M
BSI Nano Operating Income	-94.10M	-71.80M	2.30M
Corporate, Eliminations and Other Operating Income	-146.60M	-137.00M	-121.90M
Total BSI Operating Income	-50.90M	48.80M	218.20M
BEST Operating Income	20.30M	19.40M	34.90M
Operating Income (Total)	-30.60M	68.20M	253.10M

Capital Expenditures

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
BSI BioSpin Capital Expenditures	11.40M	22.80M
BSI CALID Capital Expenditures	25.30M	34.10M
BSI Life Science Capital Expenditures	36.70M	56.90M
BSI Nano Capital Expenditures	36.50M	19.30M
Corporate Capital Expenditures	16.00M	14.80M
Total BSI Capital Expenditures	89.20M	91.00M
BEST Capital Expenditures	13.80M	24.30M

Data Source: Fiscal.ai Last updated: Aug 5, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 5, 2026

Data Sources Report a data error